Ferhat BACAKSIZ, FARUK KILINÇ, ZAFER PEKKOLAY, ALPASLAN KEMAL TUZCU

Erkek hipogonadotropik hipogonadizm tanılı hastaların fertilizasyon oranlarının belirlenmesi ve fertilizasyonu etkileyen faktörlerin değerlendirilmesi

Amaç: Hipogonadotropik hipogonadizm tanısıyla takip edilen hastaları retrospektif olarak tarayıp, bu hastalardaki fertilizasyon oranlarını, hormonal profili ve fertilizasyon düzeyini etkileyen faktörleri araştırmayı amaçladık. Gereç ve Yöntem: 2009-2015 yılları arasında Endokrinoloji polikliniğine başvurmuş olan erkek hipogonadizmi tanılı hastalar retrospektif olarak incelendi. 18 yaşından büyük 55 erkek hasta çalışmaya alındı.Hasta dosyalarından hastaların yaşı, boyu, ağırlığı ve testosteron düzeyleri incelendi. Tedavi öncesi (TÖ) ve tedavi sonrası (TS) testosteron,spermiogram parametreleri ve skrotal ultrasonografideki testis volümleri karşılaştırıldı. Bulgular: Ortalama testosteron seviyesiTÖ: 0.88±1,3 (ng/ml), TS: 5.98±2.96 (ng/ml) olup, artış istatistiksel olarak anlamlıydı (p

Objective: We aimed to investigate retrospectively the patients who were followed up with hypogonadotropic hypogonadism and the factors affecting fertilization levels, hormonal profile status and fertilization rates in these patients. Material and Methods: Patients with male hypogonadism who were admitted to the endocrinology out patient clinic between 2009-2015 were retrospectively studied. 55 male patientsover 18 years of age were included in the study. Patients' age, height, weight and testosterone levels were examined. Before and after treatment, testosterone, spermiogram parameters and testicular volumes in scrotal ultrasonography were compared. Results: The mean testosterone level was 0.88 ± 1.3 (ng / ml) and posttreatment testosterone levels: 5.98 ± 2.96 (ng / ml), and the increase was statistically significant (p

PDF

___

1. Shlomommed L, Kleinberg D. Hypogonadotropic Hypogonadism. In: Larsen R,Kronenberg HM, Melmed S (eds), Williams Text Book of Endocrinology (10nd ed) Saunders,Philadelphia 2003; 177-279.

2. Jockenhövel F, Male Hypogonadısm, First Edition, UNIMED Verlag AG, Bremen 2004;12-118.

3. Burris AS, Rodbard HW, Winters SJ, et al. Gonadotropin therapy in men with isolatedhypogonadotropic hypogonadism: The response to human chorionic gonadotropin is predictedby initial testicular size. J Clin Endocrinol Metab 1988; 66: 1144-9.

4. Hani Hosseinifar, Marjan Sabbaghian, Mohammad Chehrazi, et al. Assessment of Deoxyribonucleic Acid Fragmentation Index, Testicular Volume, Semen Parameters, and Hormone Profile in Gonadotropin-treated Men With Hypogonadotropic Hypogonadism. Infertility Urology 2013; 82: 1291-5.

5. Pasquali R, Patton L, Gambineri A. Obesity and infertility. Curr Opin Endocrinol. Diabetes Obes 2007; 14: 482-7.

6. Corona G, Rastrelli G, Morelli A, et al. Hypogonadism and metabolic syndrome. J Endocrinol Invest 2011; 34: 557-67.

7. Corona G, Monami M, Rastrelli G, et al. Type 2 diabetes mellitus and testosterone: a metaanalysis study. Int J Androl 2011; 34: 528-40.

8. Corona G, Monami M, Rastrelli G, et al. Testosterone and metabolic syndrome: a metaanalysis study. J Sex Med 2011; 8: 272-83.

9. Corona G, Mannucci E, Forti G, Maggi M. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? Int J Androl 2009; 32: 431-41.

10. Saad F, Aversa A, Isidori AM, et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol 2011; 165:675-85.

11. A.A. Mac Donald, A.W. Stewart, and C.M. Farquhar. Body mass index in relation to semen quality and reproductive hormones in New Zeland men: a cross-sectional study in fertility clinics. Hum Reprod 2013; 28: 3178-87.

12. Sermondade N, Faure C, Fezeu L, Shayeb AG, Bonde JP, Jensen TK, Van Wely M, Cao J, Martini AC, Eskandar M et al. BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update 2012; 19: 1-11.

13. Ishikawa T, Ooba T, Kondo Y, et al. Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism. Fertil Steril. 2007; 88: 1697-9. 61.

14. Farhat R, Al-zidjali F, Alzahrani AS. Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary 2010; 13: 105-10.

15. Miyagawa Y, Tsujimura A, Matsumiya K, et al. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30- year retrospective study. J Urol 2005; 173: 2072-5.

16. Liu PY, Gebski VJ, Turner L, et al. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod 2002; 17: 625-33.

17. David W. Warne, Genevieve Decosterd, Hiroshi Okada, et al. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil Steril 2009; 92: 594-604.

18. Liu PY, Gebski VJ, Turner L, et al. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod 2002; 17: 625-33.

19. Burris AS, Rodbard HW, Winters SJ, Sherins RJ. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 1988; 66: 1144-51.

20. Jones TH, Darne JF. Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf) 1993; 38: 203–8.

21. Buchter D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of42 cases. Eur J Endocrinol 1998; 139:298– 303.

22. Dwyer AA. Best Practice 92 &Research Clinical Endocrinology&Metabolism 2015; 29: 91-103.

23. Peter Y. Liu, H. W. Gordon Baker, Veena Jayadev, et al. Induction of Spermatogenesis and Fertility during Gonadotropin Treatment of Gonadotropin-Deficient Infertile Men: Predictors of Fertility Outcome. J ClinEndocrinol Metab 2009; 94: 801-8.

24. Russell LD, Ren HP, SinhaHikim I, Schulze W, SinhaHikim AP. A comparative study in twelve mammalian species of volume densities, volumes, and numerical densities of selected testis components, emphasizing those related to the Sertoli cell. Am J Anat 1990; 188: 21-30.

25. Corona G, Rastrelli G, Vignozzi L, Mannucci E &Maggi M. How to recognizelate-onset hypogonadism in men with sexual dysfunction. Asian J Androl 2012; 14: 251-9.